TREATMENT OF NON INFECTIOUS UVEITIS THROUGH EYE INJECTIO
Not Applicable
- Conditions
- Health Condition 1: H309- Unspecified chorioretinal inflammation
- Registration Number
- CTRI/2023/03/050981
- Lead Sponsor
- GSVM MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Newly diagnosed patients of non-infectious anterior uveitis. (2) Newly diagnosed patients of non-infectious intermediate uveitis. (3) Newly diagnosed patients of non-infectious posterior uveitis
Exclusion Criteria
(1) Patients not willing to participate or ready for follow up.
(2) Patients with uncontrolled blood sugar.
(3) Patients with any ocular disease other than uveitis.
(4) Patients contraindicated for suprachoroidal injection eg. thinned sclera, scleritis, staphylococcus.
(5) Patients of hypersensitivity for Triamcinolone.
(6) Patients diagnosed of any other posterior segment pathologies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) BCVA <br/ ><br>2) Slit lamp examination <br/ ><br>3) Intra ocular pressure <br/ ><br>Timepoint: 3 days after injection
- Secondary Outcome Measures
Name Time Method BCVA <br/ ><br>Slit lamp examination <br/ ><br>Intraocular pressure <br/ ><br>Indirect ophthalmoscopic assessment of fundusTimepoint: 15days after injection;BCVA <br/ ><br>Slit lamp examination <br/ ><br>Intraocular pressure <br/ ><br>Indirect ophthalmoscopic assessment of fundus <br/ ><br>USG B Scan assessment of posterior segment <br/ ><br>OCT to assess resolution of Macular oedemaTimepoint: 1month after injection